| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On August 21, 2007
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 1997S-0163
|
| Dietary Supplements, Courtesy Letters (Letters of Objection)
|
|
|
|
|
| 1998N-0359
|
| Program priorities/Center for Food Safety & Applied Nutrition
|
|
|
|
|
| 2003D-0044
|
| Reporting Results for Studies Evaluating Diagnostic Tests
|
|
|
|
|
| 2003P-0409
|
| Reclassification for Moblie Bearing Knees from Class III and Class II
|
|
|
|
|
| 2004N-0226
|
| Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 010
|
|
|
|
|
| 2004N-0382
|
| Food Labeling: Safe Handling Statements: Labeling of Shell Eggs
|
|
|
|
|
| 2005D-0112
|
| Guidance for Industry on Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics
|
|
|
|
|
| 2005N-0272
|
| Irradiation in the Production, Processing & Handling of Food
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| 2006F-0059
|
| Safe Use of Polydextrose as a Bulking Agent, Formulation Aid, Humectant and Texturizer in All Foods, except Meat and Poultry (FAP 6A4763)
|
|
|
|
|
| 2006N-0104
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format
|
|
|
|
|
| 2006N-0238
|
| Debarment of Maria Anne Kirkman Campbell
|
|
|
|
|
| 2006N-0454
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
|
|
|
|
|
| 2006P-0281
|
| Determination of Orudis KT (ketoprofen, 12.5 mg) Oral Tablet
|
|
|
|
|
| 2006P-0379
|
| To urge the FDA's prompt action to cancel the GRAS desgnation for diacetyl
|
|
|
|
|
| 2006P-0505
|
| ANDA for Ursodial Capsules USP, 100 mg 200 mg, and 400 mg
|
|
|
|
|
| 2007D-0125
|
| Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims
|
|
|
|
|
| 2007D-0168
|
| Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations
|
|
|
|
|
| 2007D-0173
|
| Guidance for Industry on Protecting the Rights, Safety, and Welfare of Study Subjects - Supervisory Responsibilities of Investigators
|
|
|
|
|
| 2007N-0236
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; New Animal Drug Applications and Supporting Regulations, and Form FDA 356V
|
|
|
|
|
| 2007N-0264
|
| Revisions to the Requirements Applicable to Blood, Blood Components and Source Plasma, Direct Final Rule
|
|
|
|
|
| 2007N-0317
|
| Agency Information Collection Activities; Proposed Collection; Comment Request, Guidance for Industry on Pharmacogenomic Data Submissions; Extension
|
|
|
|
|
| 2007P-0065
|
| To increase print size of direct-to-consumer advertisements
|
|
|
|
|
| 2007V-0222
|
| Projector for a Laser Light Show
|
|
| |
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET 20616
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20617
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20618
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20619
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20620
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20621
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20622
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20623
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20624
|
| Enzmatic
|
| Vol #:
|
| 180
|
|
| | | | | | | |
|
| |
|
| LET 20625
|
| Enzmatic
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20626
|
| Enzmatic
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20627
|
| Enzmatic
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20628
|
| Enzmatic
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20629
|
| Enzmatic
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20630
|
| Enzmatic
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20631
|
| Enzmatic
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20632
|
| Enzmatic
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20633
|
| Josefino Gonzales
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20634
|
| Sciff Nutrition International Inc.
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20635
|
| Sciff Nutrition International Inc.
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20636
|
| Sciff Nutrition International Inc.
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20637
|
| Sciff Nutrition International Inc.
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20638
|
| Sciff Nutrition International Inc.
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20639
|
| Sciff Nutrition International Inc.
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20640
|
| Sciff Nutrition International Inc.
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20641
|
| Sciff Nutrition International Inc.
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20642
|
| Sciff Nutrition International Inc.
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20643
|
| Sciff Nutrition International Inc.
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20644
|
| Sciff Nutrition International Inc.
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20645
|
| Sciff Nutrition International Inc.
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20646
|
| The EFA Focus Company
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20647
|
| Bayer HealthCare
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20648
|
| Golden Temple
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20649
|
| HERB PHARM
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20650
|
| The Coromega Company, Inc.
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20651
|
| Applied Cognitive Sciences LLC
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20652
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20653
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20654
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20655
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20656
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20657
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20658
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20659
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20660
|
| NBTY
|
| Vol #:
|
| 180
|
|
|
|
|
| LET 20661
|
| MOLEAC
|
| Vol #:
|
| 180
|
|
| | | | | | | | |
|
| |
|
| 1997S-0163
|
| Dietary Supplements, Courtesy Letters (Letters of Objection)
|
|
| |
|
| LET 945
|
| FDA/CSFAN to Wellness International Network, Ltd
|
| Vol #:
|
| 28
|
|
|
|
|
| LET 946
|
| FDA/CFSAN to Hansen Beverage Company
|
| Vol #:
|
| 28
|
|
|
|
|
| LET 947
|
| FDA/CFSAN to Microgravity Enterprises, Inc.
|
| Vol #:
|
| 28
|
|
|
|
|
| LET 948
|
| FDA/CFSAN to University Lab Technologies
|
| Vol #:
|
| 28
|
|
|
|
|
| LET 949
|
| FDA/CFSAN to Konsyl Phatmaceuticals, Inc.
|
| Vol #:
|
| 28
|
|
|
|
|
| LET 950
|
| FDA/CFSAN to Technical Marketing Manager
|
| Vol #:
|
| 28
|
|
|
|
|
| LET 951
|
| FDA/CFSAN to Herbal Extract Company of North America
|
| Vol #:
|
| 28
|
|
|
|
|
| LET 952
|
| FDA/CFSAN to Cardiac Wellness Supplements
|
| Vol #:
|
| 28
|
|
|
|
|
| 1998N-0359
|
| Program priorities/Center for Food Safety & Applied Nutrition
|
|
|
|
|
| EC 406
|
| American Frozen Food Institute
|
| Vol #:
|
| 12
|
|
|
|
|
| 2003D-0044
|
| Reporting Results for Studies Evaluating Diagnostic Tests
|
|
|
|
|
| EC 7
|
| Miracle 2 Soaps
|
| Vol #:
|
| 1
|
|
| |
|
| 2003P-0409
|
| Reclassification for Moblie Bearing Knees from Class III and Class II
|
|
|
|
|
| LET 1
|
| FDA/CDRH to Orthopedic Surgicla Manufacturers Association (OSMA)
|
| Vol #:
|
| 6
|
|
|
|
|
| 2004N-0226
|
| Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 010
|
|
|
|
|
| EC 27
|
| Mrs. Vonda Clerke
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 28
|
| Mr. Luis Perez
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 29
|
| Dr. Sara Stebbins
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0382
|
| Food Labeling: Safe Handling Statements: Labeling of Shell Eggs
|
|
|
|
|
| NFR 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005D-0112
|
| Guidance for Industry on Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics
|
|
|
|
|
| EC 44
|
| Miss. karen kistler
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0272
|
| Irradiation in the Production, Processing & Handling of Food
|
|
|
|
|
| C 3746
|
| David Peters
|
| Vol #:
|
| 61
|
|
| |
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| C 18335
|
| G. McKillop
|
| Vol #:
|
| 198
|
|
|
|
|
| 2006F-0059
|
| Safe Use of Polydextrose as a Bulking Agent, Formulation Aid, Humectant and Texturizer in All Foods, except Meat and Poultry (FAP 6A4763)
|
|
|
|
|
| BKG 2
|
| Background Material
|
| Vol #:
|
| 1
|
|
|
|
|
| EA 2
|
| Environmental Assessment
|
| Vol #:
|
| 1
|
|
|
|
|
| FONS 1
|
| Finding of No Significant Impact
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
| |
|
| C 1348
|
| B Davidson
|
| Vol #:
|
| 15
|
|
|
|
|
| C 1349
|
| M. Burton
|
| Vol #:
|
| 15
|
|
|
|
|
| C 1350
|
| A Wieland
|
| Vol #:
|
| 15
|
|
|
|
|
| C 1351
|
| M Turner
|
| Vol #:
|
| 15
|
|
|
|
|
| C 1352
|
| H McGuire
|
| Vol #:
|
| 15
|
|
|
|
|
| C 1353
|
| E Watson
|
| Vol #:
|
| 15
|
|
|
|
|
| C 1354
|
| V Mitchell
|
| Vol #:
|
| 15
|
|
|
|
|
| C 1355
|
| B Short
|
| Vol #:
|
| 15
|
|
|
|
|
| C 1356
|
| N Wood
|
| Vol #:
|
| 15
|
|
|
|
|
| C 1357
|
| B Mikton
|
| Vol #:
|
| 15
|
|
|
|
|
| C 1358
|
| L Huff
|
| Vol #:
|
| 15
|
|
|
|
|
| C 1359
|
| E Gilbertson
|
| Vol #:
|
| 15
|
|
|
|
|
| C 1360
|
| V. Plantico
|
| Vol #:
|
| 15
|
|
|
|
|
| EC 28
|
| Mrs. Deborah Singleton
|
| Vol #:
|
| 16
|
|
|
|
|
| EC 29
|
| none
|
| Vol #:
|
| 16
|
|
|
|
|
| EC 30
|
| None
|
| Vol #:
|
| 16
|
|
|
|
|
| EC 31
|
| Ms. Nancy Spuhler
|
| Vol #:
|
| 16
|
|
|
|
|
| EC 32
|
| Mrs. Kathryn West
|
| Vol #:
|
| 16
|
|
|
|
|
| EC 33
|
| Ms. carol swindell
|
| Vol #:
|
| 16
|
|
|
|
|
| EC 34
|
| Mrs. lois brachman
|
| Vol #:
|
| 16
|
|
|
|
|
| 2006P-0281
|
| Determination of Orudis KT (ketoprofen, 12.5 mg) Oral Tablet
|
|
|
|
|
| LET 2
|
| FDA/CDER to Camargo Pharmaceutical Services, LLC
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0379
|
| To urge the FDA's prompt action to cancel the GRAS desgnation for diacetyl
|
|
|
|
|
| LET 2
|
| NATIONAL JEWISH Medical and Research Center
|
| Vol #:
|
| 2
|
|
|
|
|
| 2006P-0505
|
| ANDA for Ursodial Capsules USP, 100 mg 200 mg, and 400 mg
|
|
|
|
|
| AMD 1
|
| Lachman Consultant Services, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007D-0125
|
| Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims
|
|
|
|
|
| EC 1892
|
| Mrs. Lisa Walker
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 1893
|
| Mr. john kropp
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 1894
|
| Mrs. Viviane Paolini
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 1895
|
| Ms. jacqueline wurn
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 1896
|
| Mrs. Donna Spears
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 1897
|
| Mr. Douglas Smith
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 1898
|
| Ms. Lisa Whalen
|
| Vol #:
|
| 5
|
|
| | | | | | | | |
|
| |
|
| EC 2084
|
| Ms. Carol Lutra-Johns
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 2085
|
| Ms. Victoria Dickinson
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 2086
|
| Ms. aLISA Battaglia
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 2087
|
| Ms. N Schulz
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 2088
|
| Mrs. Pamela Wellborn
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 2089
|
| Ms. Ellen Amba Caldwell
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 2090
|
| Ms. Sue Acer
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 2091
|
| Mr. Rod Peirson
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 2092
|
| Ms. Linda K
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 2093
|
| Mrs. M Wood
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 2094
|
| Mr. Richard Johnson
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 2095
|
| Mr. Bruce Gardner
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 2096
|
| Mr. William Hedal
|
| Vol #:
|
| 5
|
|
|
|
|
| EC 2097
|
| Ms. Bea Workman
|
| Vol #:
|
| 5
|
|
|
|
|
| 2007D-0168
|
| Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations
|
|
|
|
|
| LET 1
|
| Natco Pharma Limited
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007D-0173
|
| Guidance for Industry on Protecting the Rights, Safety, and Welfare of Study Subjects - Supervisory Responsibilities of Investigators
|
|
|
|
|
| C 6
|
| PhRMA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0236
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; New Animal Drug Applications and Supporting Regulations, and Form FDA 356V
|
|
|
|
|
| EC 1
|
| Mrs. Janice Carey
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0264
|
| Revisions to the Requirements Applicable to Blood, Blood Components and Source Plasma, Direct Final Rule
|
|
|
|
|
| EREG 1
|
| Y.Yogi
|
| Vol #:
|
| 1
|
|
| |
|
| 2007N-0317
|
| Agency Information Collection Activities; Proposed Collection; Comment Request, Guidance for Industry on Pharmacogenomic Data Submissions; Extension
|
|
|
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007P-0065
|
| To increase print size of direct-to-consumer advertisements
|
|
|
|
|
| LET 2
|
| FDA/CDER to Pharmacists Planning Service, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007V-0222
|
| Projector for a Laser Light Show
|
|
|
|
|
| VRA 1
|
| FDA/CDRH to Tempest International LLC
|
| Vol #:
|
| 1
|
|